What is the recommended dosage of Zofran (ondansetron) for a 16-year-old patient weighing 56.6 kg with vomiting?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ondansetron Dosing for a 16-Year-Old with Vomiting

For a 16-year-old weighing 56.6 kg with vomiting, administer ondansetron 8 mg orally (or 0.15 mg/kg IV, which equals approximately 8 mg for this patient) as a single dose, with the option to repeat every 8 hours if vomiting persists. 1, 2

Weight-Based vs. Fixed Dosing

  • For adolescents and adults, the standard dose is 8 mg orally or IV, which is appropriate for this 56.6 kg patient 1
  • The weight-based dosing of 0.15 mg/kg IV (maximum 16 mg/dose) is equivalent to approximately 8.5 mg for this patient, making the standard 8 mg dose appropriate 1
  • For patients 6 months and older, both fixed and weight-based dosing are acceptable, with this adolescent falling well within the adult dosing range 1

Route of Administration Selection

Oral administration is preferred if the patient can tolerate it:

  • Oral ondansetron 8 mg (tablet, orally dissolving tablet, or oral soluble film) is the first-line choice for mild-to-moderate vomiting 1
  • IV ondansetron 8 mg should be used if the patient has severe vomiting, lethargy, or cannot tolerate oral intake 1
  • Orally dissolving tablets are particularly useful for patients with active nausea who may have difficulty swallowing standard tablets 1

Dosing Schedule Based on Severity

For mild vomiting (1-2 episodes, no lethargy):

  • Give 8 mg orally as a single dose 1
  • Attempt oral rehydration after administration 1
  • Can repeat every 8 hours if vomiting recurs, up to maximum 24 mg/day 1

For moderate vomiting (>3 episodes with mild lethargy):

  • Administer 8 mg IV or orally 1
  • Monitor for 4-6 hours from onset of reaction 1
  • Consider IV fluids if oral rehydration fails 1

For severe vomiting (>3 episodes with severe lethargy, hypotension):

  • Give 8 mg IV (0.15 mg/kg) immediately 1
  • Place IV line for fluid resuscitation with normal saline 20 mL/kg bolus 1
  • Consider adding methylprednisolone 1 mg/kg IV (maximum 60-80 mg) for severe cases 1

Multi-Dose Regimens for Ongoing Symptoms

If vomiting persists beyond initial dose:

  • Provide 8 mg orally every 8-12 hours for up to 48 hours after initial presentation 2, 3
  • Recent high-quality evidence shows that multi-dose ondansetron (up to 6 doses over 48 hours) reduces moderate-to-severe gastroenteritis by 50% compared to placebo (adjusted OR 0.50,95% CI 0.40-0.60) 3
  • The total number of vomiting episodes within 48 hours is reduced by approximately 24% with multi-dose therapy 3

Breakthrough Vomiting Management

If ondansetron alone is insufficient:

  • Add an agent from a different drug class rather than increasing ondansetron dose 1, 4
  • Consider metoclopramide 10-20 mg orally every 6-8 hours as a dopamine antagonist 1
  • Alternative: prochlorperazine 5-10 mg orally or IV every 6 hours 1
  • For anticipatory nausea, add lorazepam 0.5-2 mg orally every 4-6 hours as needed 1, 2

Important Safety Considerations

QT prolongation concerns:

  • The 8 mg dose carries minimal QT prolongation risk compared to the previously used 32 mg IV dose, which is no longer recommended 2
  • Standard doses (8 mg) are considered safe for adolescents without significant cardiac risk 4, 2

Common pitfalls to avoid:

  • Do not exceed 16 mg as a single IV dose or 24 mg total daily dose in adolescents 1
  • Assess for non-vomiting causes (electrolyte abnormalities, increased intracranial pressure) before escalating therapy 2
  • Consider adding acid suppression if patient has difficulty distinguishing heartburn from nausea 2

Efficacy Data

  • Single-dose ondansetron reduces vomiting within 8 hours (RR 0.33, NNT=2) in pediatric gastroenteritis 5
  • Reduces need for IV hydration by 56% (RR 0.44) and hospitalization by 51% (RR 0.49) 6
  • Mean decrease in nausea score is 4.0 points on a 10-point scale across all routes of administration 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ondansetron Dosing for Nausea Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antiemetic Therapy for Nausea and Vomiting

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.